Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study

AALL1931, a phase 2/3 study conducted in collaboration with the Children’s Oncology Group, investigated the efficacy and safety of JZP458 (asparaginase erwinia chrysanthemi [recombinant]-rywn), a recombinant Erwinia asparaginase derived from a novel expression platform, in patients with acute lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Maese, Luke, Loh, Mignon L., Choi, Mi Rim, Lin, Tong, Aoki, Etsuko, Zanette, Michelle, Agarwal, Shirali, Iannone, Robert, Silverman, Jeffrey A., Silverman, Lewis B., Raetz, Elizabeth A., Rau, Rachel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651770/
https://www.ncbi.nlm.nih.gov/pubmed/36108304
http://dx.doi.org/10.1182/blood.2022016923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651770/
https://www.ncbi.nlm.nih.gov/pubmed/36108304
http://dx.doi.org/10.1182/blood.2022016923

Ejemplares similares